News
Recent news about Panacea Capital and select portfolio companies
February 10, 2026
Kainova Therapeutics Secures $32M CAD to Accelerate Development of Immuno-Oncology and Inflammation Therapies
February 10, 2026
Kainova Therapeutics Secures $32M CAD to Accelerate Development of Immuno-Oncology and Inflammation Therapies
February 10, 2026
Kainova Therapeutics secures $CAD 32 million to accelerate the development of its immuno-oncology and inflammation portfolio.
February 10, 2026
Kainova Therapeutics secures $CAD 32 million to accelerate the development of its immuno-oncology and inflammation portfolio.
January 30, 2026
HiRO and Hallym University Sacred Heart Hospital Sign Strategic MOU to Advance Drug Development
Harvest Integrated Research Organization (HiRO), a boutique global CRO, is pleased to announce the signing…
January 30, 2026
HiRO and Hallym University Sacred Heart Hospital Sign Strategic MOU to Advance Drug Development
Harvest Integrated Research Organization (HiRO), a boutique global CRO, is pleased to announce the signing…
January 30, 2026
US FDA Regulatory Meetings
Understanding the various types of regulatory meetings available with the US FDA is crucial for…
January 30, 2026
US FDA Regulatory Meetings
Understanding the various types of regulatory meetings available with the US FDA is crucial for…
January 29, 2026
Rescuing a Rare Disease Trial: Accelerating MRCT RA Submissions for a Taiwan Biotech Company
This case study highlights HiRO's effective intervention in accelerating the regulatory submission process for a…
January 29, 2026
Rescuing a Rare Disease Trial: Accelerating MRCT RA Submissions for a Taiwan Biotech Company
This case study highlights HiRO's effective intervention in accelerating the regulatory submission process for a…